{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:45:06Z","timestamp":1786221906996,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-030046"],"award-info":[{"award-number":["INV-030046"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijid.2025.107919","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:55:26Z","timestamp":1746273326000},"page":"107919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preschool age participation in mass drug administration: Analyzing the impact on community-wide schistosomiasis control"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-4244","authenticated-orcid":false,"given":"John R.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107919_bib0001","series-title":"WHO Guideline on control and elimination of human schistosomiasis","year":"2022"},{"key":"10.1016\/j.ijid.2025.107919_bib0002","series-title":"Schistosomiasis: progress report 2001\u20132011, strategic plan 2012\u20132020","year":"2013"},{"key":"10.1016\/j.ijid.2025.107919_bib0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14656566.2024.2333372","article-title":"Current drug strategies for the treatment and control of schistosomiasis","volume":"25","author":"Villamizar-Monsalve","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijid.2025.107919_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2007.01.005","article-title":"Schistosomiasis in African infants and preschool children: to treat or not to treat?","volume":"23","author":"Stothard","year":"2007","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijid.2025.107919_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pt.2013.02.001","article-title":"Schistosomiasis in African infants and preschool children: let them now be treated!","volume":"29","author":"Stothard","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijid.2025.107919_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006144","article-title":"Paediatric schistosomiasis: what we know and what we need to know","volume":"12","author":"Osakunor","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0007","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2214-109X(17)30187-0","article-title":"Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial","volume":"5","author":"Coulibaly","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2025.107919_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244695","article-title":"A systematic review and meta-analysis quantifying schistosomiasis infection burden in pre-school aged children (PreSAC) in sub-Saharan Africa for the period 2000\u20132020","volume":"15","author":"Kalinda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107919_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301464","article-title":"Effects of paediatric schistosomiasis control programmes in sub-Saharan Africa: a systematic review","volume":"19","author":"Vere","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107919_bib0011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(23)00048-8","article-title":"Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in C\u00f4te d\u2019Ivoire and Kenya: an open-label, partly randomised, phase 3 trial","volume":"23","author":"N\u2019Goran","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0012","doi-asserted-by":"crossref","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","article-title":"Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials","volume":"8","author":"Zwang","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0013","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1017\/S0031182009006350","article-title":"Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes","volume":"136","author":"Webster","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.ijid.2025.107919_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4269\/ajtmh.2011.10-0642","article-title":"Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis","volume":"84","author":"Gurarie","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2025.107919_bib0015","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/S1473-3099(17)30490-5","article-title":"Schistosomiasis in the first 1000 days","volume":"18","author":"Freer","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0016","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1017\/S0031182017000014","article-title":"One hundred years of neglect in paediatric schistosomiasis","volume":"144","author":"Bustinduy","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.ijid.2025.107919_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005524","article-title":"Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis","volume":"12","author":"Ezeamama","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.apar.2016.06.003","article-title":"Studies of the transmission dynamics, mathematical model development and the control of schistosome parasites by mass drug administration in human communities","volume":"94","author":"Anderson","year":"2016","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.ijid.2025.107919_bib0019","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/infdis\/jix496","article-title":"A persistent hotspot of Schistosoma mansoni infection in a five-year randomized trial of praziquantel preventative chemotherapy strategies","volume":"216","author":"Wiegand","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13071-020-04409-3","article-title":"The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?","volume":"13","author":"Kura","year":"2020","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ijid.2025.107919_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006717","article-title":"The design of schistosomiasis monitoring and evaluation programmes: the importance of collecting adult data to inform treatment strategies for Schistosoma mansoni","volume":"12","author":"Toor","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0022","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-3156.2003.01176.x","article-title":"Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control","volume":"9","author":"Kabatereine","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2025.107919_bib0023","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1371\/journal.pntd.0001143","article-title":"Schistosoma haematobium treatment in 1\u20135 year old children: safety and efficacy of the antihelminthic drug praziquantel","volume":"5","author":"Mutapi","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijid.2025.107919_bib0024","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0035-9203(73)90079-5","article-title":"Egg output stability and the epidemiology of Schistosoma haematobium. I. Variation and stability in Schistosoma haematobium egg counts","volume":"67","author":"McCullough","year":"1973","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2025.107919_bib0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0031182000080896","article-title":"A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man","volume":"110","author":"Fulford","year":"1995","journal-title":"Parasitology"},{"key":"10.1016\/j.ijid.2025.107919_bib0027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apar.2016.08.002","article-title":"Soil-transmitted helminths: mathematical models of transmission, the impact of mass drug administration and transmission elimination criteria","volume":"94","author":"Truscott","year":"2016","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.ijid.2025.107919_bib0028","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2017.02.002","article-title":"Measuring and modelling the effects of systematic non-adherence to mass drug administration","volume":"18","author":"Dyson","year":"2017","journal-title":"Epidemics"},{"key":"10.1016\/j.ijid.2025.107919_bib0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/trstmh\/trad079","article-title":"Patterns of individual compliance with anthelmintic treatment for soil-transmitted helminth infections in southern Ethiopia over six rounds of community-wide mass drug administration","volume":"118","author":"Maddren","year":"2024","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:28:44Z","timestamp":1786220924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"alternative-id":["S1201971225001420"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107919","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.06.25323487","asserted-by":"object"}]},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preschool age participation in mass drug administration: Analyzing the impact on community-wide schistosomiasis control","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107919"}}